Profil
In addition to co-founding Avogadro Capital, Mr. Bianco is a Co-Founder of Cell Therapeutics, Inc. and has been Executive Vice President of Finance and Administration since February 1, 1992.
Previously, he was a Director of Cell Therapeutics from September 1991 to April 1992 and from April 1993 to April 1995.
From January 1989 to January 1992, he was Vice President of Risk Management for Deutsche Bank Capital Corporation.
Mr. Bianco received an MBA from New York University and is a Certified Public Accountant.
Postes actifs de Lou A. Bianco
| Sociétés | Poste | Début |
|---|---|---|
DiaKine Therapeutics, Inc.
DiaKine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Directeur/Membre du Conseil | 18/08/2010 |
Anciens postes connus de Lou A. Bianco
| Sociétés | Poste | Fin |
|---|---|---|
| CTI BIOPHARMA CORP. | Fondateur | 13/03/2017 |
Deutsche Bank Capital Corp.
Deutsche Bank Capital Corp. Investment Banks/BrokersFinance Provides securities brokerage services | Corporate Officer/Principal | 01/01/1992 |
Formation de Lou A. Bianco
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
DiaKine Therapeutics, Inc.
DiaKine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank Capital Corp.
Deutsche Bank Capital Corp. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
















